Obesity Due to Melanocortin 4 Receptor Deficiency
1 clinical trials · Condition
◉ Watch Obesity Due to Melanocortin 4 Receptor Deficiency
| Record | Firm | Date |
|---|---|---|
| Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity (NCT03013543) | Rhythm Pharmaceuticals, Inc. | 2017-02-10 |
Track Obesity Due to Melanocortin 4 Receptor Deficiency automatically
Every clearance here is in the API, with alerts when new ones post.